Rockstroh J K, Wasmuth J-C
Medizinische Klinik und Poliklinik I, Universitätsklinikum Bonn, Sigmund-Freud-Str. 25, 53127, Bonn, Deutschland.
Internist (Berl). 2016 Aug;57(8):773-83. doi: 10.1007/s00108-016-0099-6.
In Europe depending on the country 15-80 % of all individuals infected with human immunodeficiency virus (HIV) are either not aware of the diagnosis or are diagnosed later. An early HIV diagnosis could, however, considerably improve the prognosis of individuals infected with HIV and decrease the risk of new infections; therefore, in the presence of indicator diseases, such as sexually transmitted diseases, oral thrush, herpes zoster and lymphoma, the performance of a HIV test is of utmost importance. A newly diagnosed HIV infection represents an indication for starting antiretroviral combination therapy independent of the clinical stage or CD4 cell count. A decline of the viral burden to below the limit of detection and subsequent continuous suppression of viral replication can prevent transition from HIV to acquired immune deficiency syndrome (AIDS) and if started early enough a normal life expectancy can be achieved. Challenges which remain in HIV therapy are the lifelong daily intake of medication and the complex long-term adverse effects.
在欧洲,根据国家不同,感染人类免疫缺陷病毒(HIV)的所有个体中有15% - 80%要么不知道自己的诊断结果,要么是后来才被诊断出来。然而,早期HIV诊断可以显著改善HIV感染者的预后,并降低新感染的风险;因此,在存在性传播疾病、口腔念珠菌病、带状疱疹和淋巴瘤等指示性疾病的情况下,进行HIV检测至关重要。新诊断出的HIV感染意味着开始抗逆转录病毒联合治疗的指征,而不考虑临床阶段或CD4细胞计数。将病毒载量降至检测限以下并随后持续抑制病毒复制可以防止从HIV转变为获得性免疫缺陷综合征(AIDS),并且如果足够早地开始治疗,可以实现正常的预期寿命。HIV治疗中仍然存在的挑战是终身每日服药以及复杂的长期不良反应。